Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Sputum from patients with primary ciliary dyskinesia contains high numbers of dysfunctional neutrophils and inhibits efferocytosis

Fig. 3

Expression of activation markers on blood and sputum neutrophils in PCD and bronchiectasis. Peripheral blood neutrophils from patients with PCD (PCD blood, n = 9) and non-PCD, non-CF bronchiectasis (BE blood, n = 5) and purified sputum cells from patients with PCD (PCD sputum, n = 9) and non-PCD, non-CF bronchiectasis (BE sputum, n = 5) were labeled with antibodies directed against various activation markers. Using flow cytometry, the levels of A CD66b, B CD16, C CD11b, D CD62L, E CD10 were determined. Data are shown as A–C, E median fluorescence intensities measured in the neutrophil population (defined as live CD16 + CD66b + cells) or as D the percentage of marker-positive cells within the neutrophil population (defined as live CD16 + CD66b + cells)

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us